 |
CORSO: Challenges in Breast Cancer Management
Chieti, 22 November 2019 |
Direttori: Teresa Gamucci, Clara Natoli, Patrizia Vici |
| CREDITI ECM: 7 |
SCARICA IL PDF... |
|
|
|
|
|
|
|
|
| PROGRAMMA DEL CORSO (CLICCARE SULLE ICONE PER SCARICARE LE SLIDES) |
| 09:30 |
Registration & Welcome coffee |
|
|
|
| 10:00 |
Objectives of the course |
Teresa Gamucci, Clara Natoli, Patrizia Vici |
|
|
|
| Session I |
| Moderatori: Clara Natoli, Corrado Ficorella |
|
| 10:10 |
Therapeutic approach to HER2+ breast cancer in the neoadjuvant and adjuvant setting |
Patrizia Vici, Roma |
|
|
| 10:30 |
Therapeutic approach to triple negative breast cancer in the neoadjuvant and adjuvant setting |
Teresa Gamucci, Roma |
|
|
| 10:50 |
Discussants |
Maria Teresa Scognamiglio, Maria Mancini |
|
|
|
| Session II |
| Moderatori: Patrizia Vici, Nicola D'Ostilio |
|
| 11:20 |
New imaging techniques for early breast cancer detection |
Marzia Muzi, Ortona (CH) |
|
|
| 11:40 |
Bone protection during adjuvant hormone therapy |
Francesco Pantano, Roma |
|
|
| 12:00 |
Interactions between new systemic agents and radiotherapy for metastatic breast cancer |
Lucia Anna Ursini, Chieti |
|
|
| 12:20 |
The GIM-13 trial: updates |
Giorgio Mustacchi, Trieste |
|
|
| 12:40 |
Complementary medicine in breast cancer
management |
Ettore Cianchetti, Chieti |
|
|
| 13:00 |
Discussants |
Jamara Giampietro, Eriseld Krasniqi |
|
|
|
|
|
| Session III |
| Moderatori: Teresa Gamucci, Amedeo Pancotti, Dimitri Luisi |
|
| 14:30 |
Therapeutic approach to HER2+ breast cancer in the metastatic setting |
Giuliana D'Auria, Roma |
|
|
| 14:50 |
The therapeutic approach to triple negative breast cancer in the metastatic setting |
Laura Pizzuti, Roma |
|
|
| 15:10 |
The growing role of CDK4-6 inhibitors in the therapeutic strategy of metastatic breast cancer: how to choose? |
Katia Cannita, L'Aquila |
|
|
| 15:30 |
Discussants |
Francesca Di Giandomenico, Laura Iezzi |
|
|
|
|
|
| Session IV |
| Moderatori: Fiamma Buttitta, Maddalena Barba |
|
| 16:20 |
New developments of immunotherapy
in breast cancer management |
Cinzia Solinas, Aosta |
|
|
| 16:40 |
Trastuzumab biosimilars: therapeutic continuity, switch, interchangeability |
Clara Natoli, Pietro Di Marino, Chieti |
|
|
| 17:00 |
Germline mutations predisposing to breast cancer |
Liborio Stuppia, Chieti |
|
|
| 17:20 |
PARP inhibitors in breast cancer management: where we are? |
Silverio Tomao, Roma |
|
|
| 17:40 |
New drugs in clinical trials targeting breast cancer oncogenic pathways |
Antonino Grassadonia, Chieti |
|
|
| 18:00 |
Discussants |
Marinella Zilli, Pia di Stefano |
|
|
|
|